Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Clinical results for oral tridentate iron chelator ICL-670 discussed in Florence

June 12, 2002

Isradipine safely reduces cocaine-related effects

June 12, 2002

NIDA and Britannia stop phase III trials of first nonopiate detoxification agent

June 11, 2002

Dopamine uptake inhibitors and the attenuation of cocaine selfadministration

June 11, 2002

Selegiline enhances smoking cessation rates among nicotine-dependent smokers

June 11, 2002

The NMDA receptor antagonist LY-235959 attenuates cocaine conditioning in rats

June 11, 2002

Lofexidine is safe and attenuates withdrawal signs during opiate detoxification

June 10, 2002

FDA advisory committee hands down positive opinion on acamprosate NDA

May 14, 2002

Phase IIa trial of TA-CD for cocaine addiction begins

April 4, 2002

Vivitrex enters phase III trial in alcohol-dependent patients, study in opiate users

April 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...